Organigram Global (OGI) Cash from Investing Activities (QoQ) (2018 - 2026)
Organigram Global (OGI) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.72% |
| Mar 31, 2025 | 83.71% |
| May 31, 2021 | -550.24% |
| Feb 28, 2021 | 116.18% |
| Nov 30, 2020 | 108.89% |
| Aug 31, 2020 | -660.80% |
| May 31, 2020 | -34,442.58% |
| Aug 31, 2019 | 144.34% |
| May 31, 2019 | -197.78% |
| Feb 28, 2019 | -45.41% |
| Nov 30, 2018 | 175.33% |